Literature DB >> 27541926

CHOROIDAL BLOOD FLOW VISUALIZATION IN HIGH MYOPIA USING A PROJECTION ARTIFACT METHOD IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Ichiro Maruko1, Richard F Spaide, Hideki Koizumi, Shota Sawaguchi, Takahiko Izumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida.   

Abstract

PURPOSE: To visualize choroidal blood flow in larger vessels in highly myopic eyes using a phenomenon of the projection artifact to in the sclera using optical coherence tomography angiography.
METHODS: The retrospective study included 92 eyes (54 patients) with greater than 8 diopters of myopia. All eyes were examined using optical coherence tomography angiography (RTVue XR Avanti; Optovue Inc, Fremont, CA). The blood flow in choroidal vessels was evaluated by attempting to directly segment the choroid and also by placing the segmentation layer behind the choroid, within the sclera. Subfoveal choroidal thickness was also measured at the same time. The authors also evaluated the 54 normal eyes (54 cases) without high myopia as a control group.
RESULTS: Segmentation artifacts occurred in 68 cases (73.9%) and precluded direct visualization of the choroidal blood flow in larger vessels. When the segmentation slab was placed posterior to the choroid within the sclera, the choroidal blood flow was visualized in 41 eyes (44.6%). The mean subfoveal choroidal thickness in eyes with visualization of choroidal blood flow was thinner than without visualization (50.3 ± 42.2 μm vs. 100.3 ± 44.4 μm, P < 0.01). Choroidal blood flow in larger vessels was imaged in no control eye.
CONCLUSION: The choroidal vessel anatomy could be imaged by detecting flow using the projection artifact in the sclera with optical coherence tomography angiography. This technique may be useful in estimating the vascularity of the choroid.

Entities:  

Mesh:

Year:  2017        PMID: 27541926     DOI: 10.1097/IAE.0000000000001324

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Artifacts in Optical Coherence Tomography Angiography.

Authors:  Pasha Anvari; Maryam Ashrafkhorasani; Abbas Habibi; Khalil Ghasemi Falavarjani
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

2.  The Comparison of Regional RNFL and Fundus Vasculature by OCTA in Chinese Myopia Population.

Authors:  Yuanjun Li; Hamza Miara; Pingbo Ouyang; Bing Jiang
Journal:  J Ophthalmol       Date:  2018-01-31       Impact factor: 1.909

3.  A New Approach for the Segmentation of Three Distinct Retinal Capillary Plexuses Using Optical Coherence Tomography Angiography.

Authors:  Qiujian Zhu; Xiaoying Xing; Manhui Zhu; Haixiang Xiao; Lie Ma; Lili Chen; Juan Liang; You Yuan; E Song
Journal:  Transl Vis Sci Technol       Date:  2019-06-28       Impact factor: 3.283

4.  Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.

Authors:  Hyun Seung Yang; Tae Gu Kang; Hyun Park; Ji Su Heo; Jonghoon Park; Kyung Sub Lee; Sangkyung Choi
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

5.  Imaging the Deep Choroidal Vasculature Using Spectral Domain and Swept Source Optical Coherence Tomography Angiography.

Authors:  J Daniel Diaz; Jay C Wang; Patrick Oellers; Inês Lains; Lucia Sobrin; Deeba Husain; Joan W Miller; Demetrios G Vavvas; John B Miller
Journal:  J Vitreoretin Dis       Date:  2018-04-16

Review 6.  An overview of the clinical applications of optical coherence tomography angiography.

Authors:  A C S Tan; G S Tan; A K Denniston; P A Keane; M Ang; D Milea; U Chakravarthy; C M G Cheung
Journal:  Eye (Lond)       Date:  2017-09-08       Impact factor: 3.775

7.  Visualizing large choroidal blood flow by subtraction of the choriocapillaris projection artifacts in swept source optical coherence tomography angiography in normal eyes.

Authors:  Ichiro Maruko; Taizo Kawano; Hisaya Arakawa; Taiji Hasegawa; Tomohiro Iida
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.